Systemic therapy for patienst in > 2nd relapse and TFIp > 6 m
Is there any option for non-platinum based combination
(trabectedine-PLD)?
BRCA mutated
•
Previous use of PARPi
•
Previous use of Beva or Beva
not used in 1st or 2nd line
•
TFIp < 12 months
PLD is active in BRCAmut patients
with a PFI < 12 months
S. Kaye et al. J Clin Oncol 2011
